Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1995 2
1996 1
1997 2
1998 1
1999 1
2001 3
2002 2
2003 3
2004 2
2005 5
2006 7
2007 7
2008 4
2009 9
2010 10
2011 10
2012 14
2013 9
2014 7
2015 13
2016 13
2017 10
2018 27
2019 34
2020 21
2021 40
2022 21
2023 38
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Results by year

Filters applied: . Clear all
Page 1
Time to unshackle the medical treatment of obesity in the NHS.
Ansari S, Mazaheri T, O'Donnell K, Waite M, Cann A, Abdel-Malek M, Boyle L, Tweedlie L, Scholtz S, Hameed S, Izzi-Engbeaya C, Chahal H, Tan T. Ansari S, et al. Clin Med (Lond). 2024 Apr 21;24(3):100206. doi: 10.1016/j.clinme.2024.100206. Online ahead of print. Clin Med (Lond). 2024. PMID: 38643826 Free PMC article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: abdelmalek mf. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis.
Francque SM, Hodge A, Boursier J, Younes ZH, Rodriguez-Araujo G, Park GS, Alkhouri N, Abdelmalek MF. Francque SM, et al. Among authors: abdelmalek mf. Hepatol Commun. 2024 Jan 29;8(2):e0335. doi: 10.1097/HC9.0000000000000335. eCollection 2024 Feb 1. Hepatol Commun. 2024. PMID: 38285756 Free PMC article. Clinical Trial.
284 results